Tekla Capital Management LLC Ardelyx, Inc. Put Options Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding ARDX
# of Institutions
197Shares Held
140MCall Options Held
1.25MPut Options Held
1.52M-
Janus Henderson Group PLC London, X022MShares$167 Million0.09% of portfolio
-
Black Rock Inc. New York, NY17.1MShares$129 Million0.0% of portfolio
-
State Street Corp Boston, MA14.1MShares$107 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$101 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.81MShares$51.6 Million0.8% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $1.17B
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...